Method for inducing dynamic deracemization of axially chiral biaryl compound through cocrystallization of copper-catalyzed chiral quaternary ammonium salt

Through a raceification catalyst composed of cheap metal copper and nitrogen-containing ligands, combined with co-crystallization induced dynamic deraxis, the problems of catalyst compatibility and chromatographic purification in dynamic deraxis of axial chiral aryl compounds were solved. It realizes efficient and simplified highly enantioselective synthesis, which is suitable for industrial applications.

CN119059883APending Publication Date: 2024-12-03FUDAN UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310648405.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-06-02
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Prior Art During the dynamic derailization process of axial chiral aryl compounds, racemization catalysts have poor compatibility with chiral quaternary ammonium salts, resulting in insufficient yield and enantioselectivity. Traditional methods have difficulties in chromatography purification. , hinders industrial application.

Method used

Using a highly efficient raceification catalyst composed of cheap metal copper and nitrogen-containing ligands, the enantiomer-pure chirality is constructed by co-crystallization induced dynamic deraxis using copper catalyst and nitrogen-containing ligand at room temperature or heating conditions. Biaryl compounds combine with acid quenching and extraction processes to achieve efficient synthesis.

Benefits of technology

The efficient synthesis of chiral aryl compounds with a theoretical yield of 100% was achieved, the process flow was simplified, the chromatographic purification steps were avoided, the enantioselectivity and yield were improved, and it was suitable for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004264161840000011
    Figure BDA0004264161840000011
  • Figure BDA0004264161840000021
    Figure BDA0004264161840000021
  • Figure BDA0004264161840000022
    Figure BDA0004264161840000022
Patent Text Reader

Abstract

The invention discloses a synthesis method of a chiral biaryl compound, namely dynamic deracemization of an axially chiral biaryl compound induced by cocrystallization of copper-catalyzed chiral quaternary ammonium salt. In the synthesis method, starting from a racemic biaryl compound, the chiral biaryl compound with pure enantiomer is efficiently constructed at room temperature or under a mild condition without inert gas protection by heating; comprising beta-binaphthol, a derivative of beta-binaphthol, 2 '-amino-2-hydroxy-1, 1'-binaphthalene, a derivative of 2 '-amino-2-hydroxy-1, 1'-binaphthalene, 2, 2 '-diamino-1, 1'-binaphthalene and a derivative of 2, 2 '-diamino-1, 1'-binaphthalene. The method is mild in condition, does not need expensive metal or column chromatography, is simple to operate, and has an industrial application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of chemical technology, and in particular to a method for inducing dynamic deracemization of an axial chiral compound by copper-catalyzed chiral quaternary ammonium salt cocrystallization. Background Art

[0002] Axially chiral biphenyl is an important structural unit with wide application value in natural products, drugs, chiral catalysts and organic catalysts. As representative structures of axial chirality, 2,2'-binaphthol (BINOL) and its derivatives, NOBIN and BINAM have attracted much attention due to their wide applications in asymmetric catalysis. Based on these axially chiral skeletons, various chiral catalysts and metal ligands can be obtained by simple transformation. In addition, axial chirality is also widely present in natural products and pharmacologically active substances, such as Mastigophorene A, Mastigophorene B and (+)-Isokotanin A (Formula A).

[0003]

[0004] A variety of methods have been developed to prepare axially chiral biaryl compounds, including chiral resolution, asymmetric coupling reactions, enzymatic hydrolysis / esterification, and conversion of central chirality to axial chirality. In particular, the chiral resolution process based on the cocrystal method has been widely used in industry due to its simple steps, easy operation, and high enantioselectivity that can usually be obtained without chromatographic purification. Chiral BINOLs can be prepared by cocrystallization through selective supramolecular recognition with chiral ammonium salts. In the chiral resolution process of BINOL, the enantiomer of a certain configuration crystallizes with the appropriate chiral quaternary ammonium salt through host-guest interaction, while the other enantiomer remains in the mother liquor, so the theoretical yield is limited to 50%. The cocrystallization-induced dynamic deracemization (CoIDD) used in combination with the chiral resolution process utilizes racemization catalysis to cause an enantiomer of a certain configuration to continuously isomerize into an enantiomer of another configuration in the solution. At the same time, the chiral quaternary ammonium salt will directly form co-crystals with a single enantiomer from the racemate through molecular complexation recognition, so the theoretical yield is 100% (Formula B).

[0005] Summary of the invention

[0006] The invention provides an efficient co-crystallization-induced dynamic deracemization method. Under the racemization catalysis of copper and nitrogen-containing ligands, chiral quaternary ammonium salts and substrates selectively recognize each other to produce co-crystallization, and chiral biaryl compounds with a theoretical yield of 100% can be obtained, including BINOL, NOBIN and BINAM derivatives. Under the coordination of nitrogen-containing ligands, the copper catalyst shows high efficiency and high selectivity in the racemic biaryl skeleton, and the substrate and the chiral quaternary ammonium salt form a co-crystal complex with high enantioselectivity. After acid quenching, the chiral biaryl product can be directly obtained without further chromatographic purification. This CoIDD process is easy to expand, and the chiral quaternary ammonium salt can also be well recycled.

[0007] The present invention provides a dynamic deracemization synthesis method of an enantiomerically pure biaryl compound with C1 and C2 symmetry. The synthesis method comprises the following steps: starting from a racemic biaryl compound, using a quaternary ammonium salt as a chiral reagent, a copper salt and a nitrogen-containing ligand to form a racemization catalytic system, or directly using a complex of copper and a nitrogen-containing ligand as a racemization catalyst, and efficiently constructing an enantiomerically pure chiral biaryl compound at room temperature or under heating conditions. The synthesis method is shown in reaction formula (1):

[0008]

[0009]

[0010] Among them, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 Each is independently selected from hydrogen, deuterium, alkyl, aryl, aromatic heterocyclic group, alkoxy, halogen, carboxylic acid group, carboxylate group, acyl group, amide group, nitro group, cyano group, sulfonyl group, sulfinyl group, trifluoromethyl group; wherein the aryl group is selected from phenyl group, alkyl substituted phenyl group, alkoxy substituted phenyl group, halogen substituted phenyl group; the aromatic heterocyclic group is selected from five-membered heterocyclic ring, six-membered heterocyclic ring, condensed heterocyclic ring;

[0011] Preferably, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 Each is independently selected from hydrogen, alkyl, alkoxy, halogen, carboxylate, acyl;

[0012] More preferably, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 Each is independently selected from hydrogen, alkyl, alkoxy, halogen, carboxymethyl ester, and formyl.

[0013] In the synthesis method of the present invention, the specific steps include: adding a racemic biaryl compound, a quaternary ammonium salt and a solvent under air conditions, at room temperature or under heating, using a copper salt and a nitrogen-containing ligand or directly using a complex of copper and a nitrogen-containing ligand as a racemization catalyst, reacting for 24-48 hours, filtering the generated cocrystals, washing with a solvent, stirring and dissolving the filtered solid with a mixed system of hydrochloric acid and ethyl acetate, extracting with ethyl acetate, drying with anhydrous sodium sulfate, and spinning to obtain a chiral biaryl compound.

[0014] In the present invention, the molar ratio of the racemic biaryl compound: quaternary ammonium salt: copper salt: ligand is 1:1-1.2:0.05-0.1:0.05-0.1; preferably, it is 1:1.2:0.05:0.05.

[0015] In the present invention, the quaternary ammonium salt is a chiral quaternary ammonium salt.

[0016] In the present invention, the copper salt includes one or more of copper halide, cuprous halide, copper sulfate, copper oxide, cuprous oxide, copper fluoroborate, basic copper carbonate, cuprous acetate, cupric acetate, thiophene-2-carboxylate copper (I), tetrakis(acetonitrile)tetrafluoroborate, cuprous trifluoromethanesulfonate, copper trifluoromethanesulfonate, tetraacetonitrile copper hexafluorophosphate, etc.; preferably, it is cuprous chloride.

[0017] In the present invention, the complex of copper and nitrogen-containing ligand is one or more of dihydroxy-bis-tetramethylethylenediamine copper chloride, copper phthalocyanine (II), (1,10-phenanthroline) (trifluoromethyl) copper, dichloro (1,10-phenanthroline) copper, etc.; preferably, it is dihydroxy-bis-tetramethylethylenediamine copper chloride.

[0018] In the present invention, the nitrogen-containing ligand is one or more of N,N'-di-tert-butylethylenediamine, N,N'-dimethylethylenediamine, N,N'-diethylethylenediamine, N,N'-diisopropylethylenediamine, N,N-diisopropylethylenediamine, tetramethylguanidine, metformin, 1,3-bis(dimethylamino)benzene, 2,2'-bipyridine, 6,6'-dimethyl-2,2'-bipyridine, 1,10-phenanthroline, 2,9-dimethyl-4,7-biphenyl-1,10-o-phenanthroline, 2,9-dimethyl-1,10-phenanthroline, 4,7-diphenyl-1,10-phenanthroline, 4,4'-bis(trifluoromethyl)-2,2'-bipyridine, 2,9-di-n-butyl-1,10-o-phenanthroline, etc.; preferably, it is N,N'-di-tert-butylethylenediamine.

[0019] In the present invention, the solvent is one or more of acetonitrile, dichloromethane, cyclohexane, dimethyl sulfoxide, toluene, trifluorotoluene, acetone, tetrahydrofuran, ether, methyl tert-butyl ether, ethyl acetate, methanol, ethanol, etc.; preferably, acetonitrile, dichloromethane, acetone.

[0020] In the present invention, the heating temperature is room temperature to 60°C; preferably, room temperature, 50°C or 60°C.

[0021] Furthermore, the synthesis method further comprises:

[0022] The racemic biaryl compound is dissolved in an organic solvent in a 10 mL reaction tube, and the dissolved chiral quaternary ammonium salt is added dropwise while stirring, followed by the copper salt and the nitrogen-containing ligand, and stirred for 24-48 hours at room temperature or under heating and air conditions. After the reaction is completed, the reaction mixture is filtered using a Bush funnel, washed with a cold organic solvent, and the obtained solid is stirred and dissolved with a mixed system of hydrochloric acid and ethyl acetate, and the organic phase is separated with a separatory funnel, and the aqueous phase is extracted twice with ethyl acetate, and the organic phases are combined, dried over anhydrous sodium sulfate, and spin-dried to obtain the chiral biaryl compound.

[0023] The present invention proposes that the above method can be used to synthesize enantiomerically pure chiral biaryl compounds, including β-binaphthol, derivatives of β-binaphthol, 2'-amino-2-hydroxy-1,1'-binaphthol, derivatives of 2'-amino-2-hydroxy-1,1'-binaphthol, 2,2'-diamino-1,1'-binaphthol and derivatives of 2,2'-diamino-1,1'-binaphthol.

[0024] The present invention innovatively proposes an efficient racemization catalyst composed of cheap metal copper and nitrogen-containing ligands, and successfully solves the compatibility problem between the racemization catalyst and the chiral quaternary ammonium salt in the dynamic deracemization process, thereby realizing the dynamic deracemization of axial chiral biaryl compounds. The method of the present invention has the following advantages: the racemization catalytic system in the method of the present invention is simple and cheap: the earth's abundant metal copper and nitrogen-containing ligands are cheap and easy to obtain, and the amount used is only 5 mol%. The chiral quaternary ammonium salt used in the method of the present invention can be well recycled: the chiral quaternary ammonium salt acidified in the aqueous phase is neutralized with alkali, back-extracted with dichloromethane, and spin-dried to obtain the recycled chiral quaternary ammonium salt (reference: Recommending an organic chemistry basic experiment: Synthesis and separation of BINOL [J]. University Chemistry, 2002, 03, 42-44.). The reaction conditions of the method of the present invention are mild: the reaction is carried out in air, room temperature or heating (the heating temperature is up to 60°C), and no dangerous operations such as high temperature and high pressure are required, which is conducive to large-scale synthesis. The method of the present invention is simple to operate and does not require a cumbersome chromatographic purification process. Chromatographic purification and separation are difficult, which is an important obstacle to industrial mass production. The CoIDD method can obtain the target product through simple acid hydrolysis and extraction, which is convenient and time-saving. The method of the present invention can obtain axial chiral biaryl compounds with high yield and high enantioselectivity, and the theoretical yield can reach 100%, while the theoretical yield of the traditional kinetic resolution method is only 50%, and the traditional method has problems such as difficult control of the reaction focus, resulting in decreased product enantioselectivity. The comparative experiment mentioned later in the present invention can clearly illustrate this problem: two groups of control experiments, one group uses the traditional kinetic resolution method, that is, no catalyst and ligand are added; one group adds the metal copper and nitrogen-containing ligand used in the present invention. The results are as follows: the yield of (R)-1n obtained by the traditional method is only 18%, and the ee value is 94%; the yield of (R)-1n obtained by the method of the present invention is 74%, and the ee value is 99%. The product obtained by the present invention can also be modified by coupling reactions such as Suzuki reaction, Sonogashira reaction, Kumada reaction, etc. to modify the biaryl skeleton, which is conducive to the further production of chiral ligands commonly used in commercialization, and has a high industrial application prospect. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 The HPLC chromatogram of the product obtained in Example 1 of the present invention is shown.

[0026] Figure 2 The HPLC chromatogram of the product obtained in Example 2 of the present invention is shown.

[0027] Figure 3 The HPLC chromatogram of the product obtained in Example 3 of the present invention is shown.

[0028] Figure 4 The HPLC chromatogram of the product obtained in Example 4 of the present invention is shown.

[0029] Figure 5 The HPLC chromatogram of the product obtained in Example 5 of the present invention is shown.

[0030] Figure 6 The HPLC chromatogram of the product obtained in Example 6 of the present invention is shown.

[0031] Figure 7 The HPLC chromatogram of the product obtained in Example 7 of the present invention is shown.

[0032] Figure 8 The HPLC chromatogram of the product obtained in Example 8 of the present invention is shown.

[0033] Fig. 9 The HPLC chromatogram of the product obtained in Example 9 of the present invention is shown.

[0034] Fig.10 The HPLC chromatogram of the product obtained in Example 10 of the present invention is shown.

[0035] Fig.11 The HPLC chromatogram of the product obtained in Example 11 of the present invention is shown.

[0036] Fig.12 The high performance liquid chromatogram of the product obtained in Example 12 of the present invention is shown.

[0037] Fig.13 The high performance liquid chromatogram of the product obtained in Example 13 of the present invention is shown.

[0038] Fig.14 The HPLC chromatogram of the product obtained in Example 14 of the present invention is shown.

[0039] Fig.15 The high performance liquid chromatogram of the product obtained in Example 15 of the present invention is shown.

[0040] Fig.16 The high performance liquid chromatogram of the product obtained in Example 16 of the present invention is shown.

[0041] Fig.17 The high performance liquid chromatogram of the product obtained in Example 17 of the present invention is shown.

[0042] Fig.18 The high performance liquid chromatogram of the product obtained in Example 18 of the present invention is shown.

[0043] Fig.19 The high performance liquid chromatogram of the product obtained in Example 19 of the present invention is shown.

[0044] Fig. 20 Represents the high performance liquid chromatogram of the product obtained by using the traditional kinetic separation method in the comparative experiment.

[0045] Fig.21 The high performance liquid chromatogram of the product obtained by derivatization application example 1 of the product of the present invention is shown.

[0046] Fig. 22 The HPLC chromatogram of the product obtained by derivatization application example 2 of the product of the present invention is shown.

[0047] Fig.23 The HPLC chromatogram of the product obtained by derivatization application example 3 of the product of the present invention is shown. DETAILED DESCRIPTION

[0048] The following examples are helpful for understanding the present invention, but are not limited to the contents of the present invention. In conjunction with the following specific examples and drawings, the invention is further described in detail. The process, conditions, experimental methods, etc. for implementing the present invention, except for the contents specifically mentioned below, are all common knowledge and common common sense in the art, and the present invention does not particularly limit the contents.

[0049] Example 1

[0050]

[0051] Wherein, rac means racemic reaction, mol means molar reaction, air means the reaction can be carried out under air conditions without nitrogen protection, rt means room temperature, aq. means aqueous solution, and ee means enantiomeric excess.

[0052] Under air conditions, rac-1a (143.1 mg, 0.5 mmol) and dichloromethane (3 mL) were added to a 10 mL reaction tube containing a magnetic electron. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (2 mL) was added dropwise under stirring. Then, CuCl (2.5 mg, 0.025 mmol) and N,N'-di-tert-butylethylenediamine (5.3 μL, d = 0.8 g / mL, 0.025 mmol) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 24 hours. The generated co-crystallized solid was filtered through a Bush funnel and washed with cold acetonitrile (2 mL, 0°C). The filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 20 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a light yellow solid (R)-1a (123.4 mg, 86% yield, 99% ee). 1H NMR (400MHz, Chloroform-d) δ7.93(d,J=8.9Hz,2H),7.87(d,J=8.0Hz,2H),7.37-7.33(m,4H),7.29(t,J=7.5Hz,2H),7.13(d,J=8.3Hz,2H),5.05(s,2H). 13 C NMR (101 MHz, Chloroform-d) δ 152.7, 133.4, 131.4, 129.4, 128.4, 127.4, 124.2, 124.0, 117.7, 110.9. HPLC conditions: CHIRALPAKAD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 80:20, flow rate = 1.0 mL / min, t R =15.3min is the main enantiomer, t S =18.2min is the minor enantiomer. Figure 1 .

[0053] Example 2

[0054]

[0055] Under air conditions, rac-1b (157.1 mg, 0.5 mmol) and acetonitrile (1 mL) were added to a 10 mL reaction tube containing a magnetic electron. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (0.6 mL) was added dropwise under stirring. Then, CuCl (2.5 mg, 0.025 mmol) and N,N'-di-tert-butylethylenediamine (5.3 μL, d = 0.8 g / mL, 0.025 mmol) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 24 hours. The generated co-crystallized solid was filtered through a Bush funnel and washed with cold acetonitrile (2 mL, 0°C). The filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 20 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a yellow solid (R)-1b (144.9 mg, 92% yield, 95% ee). 1 H NMR(400MHz,Chloroform-d)δ7.85(d,J=8.9Hz,2H),7.64(s,2H),7.33(d,J=8.9Hz ,2H),7.12(dd,J=8.6,1.4Hz,2H),7.04(d,J=8.6Hz,2H),5.13(s,2H),2.45(s,6H).13 C NMR (101 MHz, Chloroform-d) δ 152.0, 133.5, 131.5, 130.6, 129.6, 127.5, 124.1, 117.7, 110.8, 21.3. HPLC conditions: CHIRALPAKAD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 80:20, flow rate = 1.0 mL / min, t R =11.6min is the main enantiomer, t S =20.5min is the minor enantiomer. Figure 2 .

[0056] Example 3

[0057]

[0058] Under air conditions, rac-1c (171.2 mg, 0.5 mmol) and acetonitrile (0.6 mL) were added to a 10 mL reaction tube containing a magnetic electron. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (0.5 mL) was added dropwise under stirring. Then, [Cu(OH)Cl·TMEDA]2 (5.8 mg, 0.0125 mmol) was added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 24 h. The generated co-crystallized solid was filtered through a Bush funnel, washed with cold acetonitrile (2 mL, 0°C), and the filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 20 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated, and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a brown solid (R)-1c (153.5 mg, 90% yield, 97% ee). 1 H NMR(400MHz,Chloroform-d)δ7.85(d,J=8.9Hz,2H),7.65(s,2H),7.30(d,J=8.9Hz,2H),7.15(dd,J =8.6,1.6Hz,2H),7.07(d,J=8.6Hz,2H),4.98(s,2H),2.75(q,J=7.6Hz,4H),1.28(t,J=7.6Hz,6H). 13C NMR (101 MHz, Chloroform-d) δ 152.0, 139.8, 131.7, 130.7, 129.6, 128.6, 126.1, 124.2, 117.6, 110.9, 28.7, 15.5. HPLC conditions: CHIRALPAK IC chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 90:10, flow rate = 1.0 mL / min, t R =7.2min is the main enantiomer, t S =10.7min is the minor enantiomer. Figure 3 .

[0059] Example 4

[0060]

[0061] Under air conditions, rac-1d (177.6 mg, 0.5 mmol) and acetonitrile (0.5 mL) were added to a 10 mL reaction tube containing a magnetic electron. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (0.5 mL) was added dropwise under stirring. Then, CuCl (2.5 mg, 0.025 mmol) and N,N'-di-tert-butylethylenediamine (5.3 μL, d = 0.8 g / mL, 0.025 mmol) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 24 hours. The generated co-crystallized solid was filtered through a Bush funnel and washed with cold acetonitrile (4 mL, 0°C). The filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 30 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a green solid (R)-1d (190.0 mg, >99% yield, 99% ee). 1 H NMR (400MHz, Chloroform-d) δ7.82-7.81 (m, 4H), 7.42 (d, J = 8.7Hz, 2H), 7.20 (d, J = 8.6Hz, 2H), 7.01 (d, J = 8.8Hz, 2H), 5.40 (s, 2H). 13C NMR (101 MHz, Chloroform-d) δ 152.87, 131.70, 130.48, 129.99, 129.85, 128.21, 127.09, 125.82, 119.05, 111.05. HPLC conditions: CHIRALPAK AD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 80:20, flow rate = 1.0 mL / min, t R =8.8min is the main enantiomer, t S =16.3min is the minor enantiomer. Figure 4 .

[0062] Example 5

[0063]

[0064] Under air conditions, rac-1e (222.1 mg, 0.5 mmol) and dichloromethane (3 mL) were added to a 10 mL reaction tube containing a magnetic electron. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (2 mL) was added dropwise under stirring. Then, CuCl (2.5 mg, 0.025 mmol) and N,N'-di-tert-butylethylenediamine (5.3 μL, d = 0.8 g / mL, 0.025 mmol) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 24 hours. The generated co-crystallized solid was filtered through a Bush funnel and washed with cold acetonitrile (2 mL, 0°C). The filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 20 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a green solid (R)-1e (179.8 mg, 81% yield, >99% ee). 1 H NMR (400MHz, Chloroform-d) δ8.04 (d, J = 1.9 Hz, 2H), 7.88 (d, J = 9.0 Hz, 2H), 7.40-7.35 (m, 4H), 6.96 (d, J = 9.0 Hz, 2H), 5.09 (s, 2H). 13C NMR (101 MHz, Chloroform-d) δ 153.0, 131.9, 130.8, 130.7, 130.6, 130.4, 125.9, 119.0, 118.0, 110.7. HPLC conditions: CHIRALPAKAD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 80:20, flow rate = 1.0 mL / min, t R =9.7min is the main enantiomer, t S =20.1min is the minor enantiomer. Figure 5 .

[0065] Example 6

[0066]

[0067] Under air conditions, rac-1f (173.2 mg, 0.5 mmol) and acetonitrile (1 mL) were added to a 10 mL reaction tube containing a magnetic electron. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (0.6 mL) was added dropwise under stirring. Then, CuCl (2.5 mg, 0.025 mmol) and N,N'-di-tert-butylethylenediamine (5.3 μL, d = 0.8 g / mL, 0.025 mmol) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 24 hours. The generated co-crystallized solid was filtered through a Bush funnel and washed with cold acetonitrile (2 mL, 0°C). The filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 20 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a light yellow solid (R)-1f (149.2 mg, 86% yield, 95% ee). 1 H NMR(400MHz,Chloroform-d)δ7.82(d,J=8.9Hz,2H),7.32(d,J=8.9Hz,2H),7.19(d,J=2 .3Hz,2H),7.04(d,J=9.1Hz,2H),6.96(dd,J=9.2,2.4Hz,2H),4.96(s,2H),3.88(s,6H). 13C NMR (101 MHz, Chloroform-d) δ 156.3, 150.9, 130.3, 129.9, 128.6, 125.9, 119.7, 118.1, 111.4, 106.8, 55.3. HPLC conditions: CHIRALPAK IC chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 90:10, flow rate = 1.0 mL / min, t R =16.2min is the main enantiomer, t S =23.7min is the minor enantiomer. Figure 6 .

[0068] Example 7

[0069]

[0070] Under air conditions, rac-1g (182.6 mg, 0.5 mmol) and acetonitrile (1 mL) were added to a 10 mL reaction tube containing a magnetic electron. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (0.6 mL) was added dropwise under stirring. Then, CuCl (2.5 mg, 0.025 mmol) and N,N'-di-tert-butylethylenediamine (5.3 μL, d = 0.8 g / mL, 0.025 mmol) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 24 hours. The generated co-crystallized solid was filtered through a Bush funnel and washed with cold acetonitrile (2 mL, 0°C). The filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 20 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a light green solid (R)-1g (135.0 mg, 74% yield, 99% ee). 1 H NMR(400MHz,Chloroform-d)δ7.93(d,J=8.9Hz,1H),7.88-7.86(m,2H),7.71(d,J=8.7Hz,1H),7 .42(dd,J=8.6,1.7Hz,1H),7.38-7.27(m,5H),7.09(d,J=8.3Hz,1H),5.18(s,1H),5.11(s,1H). 13C NMR (101 MHz, Chloroform-d) δ 153.5, 152.7, 134.8, 133.2, 131.6, 131.2, 130.0, 129.4, 128.4, 127.8, 127.6, 127.5, 126.2, 124.1, 123.9, 122.1, 118.2, 117.8, 110.6, 110.1. HPLC conditions: CHIRALPAK OD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 80:20, flow rate = 1.0 mL / min, t S =9.0min is the minor enantiomer, t R =11.4min is the main enantiomer. Figure 7 .

[0071] Example 8

[0072]

[0073] Under air conditions, rac-1h (158.1 mg, 0.5 mmol) and acetonitrile (0.4 mL) were added to a 10 mL reaction tube containing a magnetic electron. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (0.4 mL) was added dropwise under stirring. Then, CuCl (2.5 mg, 0.025 mmol) and N,N'-di-tert-butylethylenediamine (5.3 μL, d = 0.8 g / mL, 0.025 mmol) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 48 hours. The generated co-crystallized solid was filtered through a Bush funnel and washed with cold acetonitrile (2 mL, 0°C). The filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 20 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a brown solid (R)-1h (102.6 mg, 65% yield, 99% ee). 1 H NMR(400MHz,Chloroform-d)δ7.95(d,J=8.9Hz,1H),7.88-7.85(m,2H),7.77(d,J=8.9Hz,1H),7.38-7.29(m,3H ),7.21-7.18(m,2H),7.02(dd,J=8.9,2.4Hz,1H),6.43(d,J=2.3Hz,1H),5.11(s,1H),5.00(s,1H),3.53(s,3H). 13C NMR (101 MHz, Chloroform-d) δ 159.1, 153.3, 152.7, 134.9, 133.2, 131.4, 131.1, 130.0, 129.5, 128.4, 127.5, 124.7, 124.2, 124.0, 117.7, 116.0, 115.1, 110.9, 109.9, 103.2, 55.1. HPLC conditions: CHIRALPAK OD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 90:10, flow rate = 1.0 mL / min, t S =16.1min is the minor enantiomer, t R =23.8min is the main enantiomer. Figure 8 .

[0074] Example 9

[0075]

[0076] Under air conditions, rac-1i (150.2 mg, 0.5 mmol) and acetonitrile (0.5 mL) were added to a 10 mL reaction tube containing a magnetic electron. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (0.5 mL) was added dropwise under stirring. Then, [Cu(OH)Cl·TMEDA]2 (5.8 mg, 0.0125 mmol) was added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 24 h. The generated co-crystallized solid was filtered through a Bush funnel and washed with cold acetonitrile (2 mL, 0°C). The filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 20 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a gray solid (R)-1i (139.0 mg, 93% yield, 97% ee). 1 H NMR(400MHz,Chloroform-d)δ7.94(d,J=8.8Hz,1H),7.86(t,J=7.3Hz,2H),7.65(s,1H),7.36-7. 24(m,4H),7.13(dd,J=10.5Hz,2H),7.04(d,J=8.4Hz,1H),5.06(s,1H),4.97(s,1H),2.46(s,3H). 13C NMR (101 MHz, Chloroform-d) δ 152.7, 152.0, 133.6, 133.4, 131.5, 131.3, 130.7, 129.6, 129.4, 129.3, 128.4, 127.5, 127.4, 124.2, 124.1, 124.0, 117.7, 111.0, 110.7, 21.3. HPLC conditions: CHIRALPAK IC chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 90:10, flow rate = 1.0 mL / min, t R =8.1min is the main enantiomer, t S =10.9min is the minor enantiomer. Fig. 9 .

[0077] Example 10

[0078]

[0079] Under air conditions, rac-1j (157.2 g, 0.5 mmol) and acetonitrile (1 mL) were added to a 10 mL reaction tube containing a magnetic electron. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (0.6 mL) was added dropwise under stirring. Then, CuCl (2.5 mg, 0.025 mmol) and N,N'-di-tert-butylethylenediamine (5.3 μL, d = 0.8 g / mL, 0.025 mmol) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 24 hours. The generated co-crystallized solid was filtered through a Bush funnel and washed with cold acetonitrile (2 mL, 0°C). The filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 20 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a light green solid (R)-1j (130.5 mg, 83% yield, 99% ee). 1 H NMR(400MHz,Chloroform-d)δ7.90(d,J=8.9Hz,1H),7.86-7.84(m,2H),7.64(s,1H),7.35-7.25(m,4H),7.16 -7.13(m,2H),7.05(d,J=8.6Hz,1H),5.08(s,1H),5.00(s,1H),2.75(q,J=7.6Hz,2H),1.28(t,J=7.6Hz,3H). 13C NMR (101 MHz, Chloroform-d) δ 152.7, 152.1, 139.9, 133.4, 131.7, 131.2, 130.8, 129.6, 129.4, 128.6, 128.3, 127.4, 126.1, 124.2, 124.2, 123.9, 117.7, 117.7, 111.1, 110.7, 28.6, 15.5. HPLC conditions: CHIRALPAKAD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 80:20, flow rate = 1.0 mL / min, t R =10.9min is the main enantiomer, t S =25.8min is the minor enantiomer. Fig.10 .

[0080] Embodiment 11

[0081]

[0082] Under air conditions, rac-1k (160.4 g, 0.5 mmol) and acetonitrile (1 mL) were added to a 10 mL reaction tube containing a magnetic electron. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (0.6 mL) was added dropwise under stirring. Then, CuCl (2.5 mg, 0.025 mmol) and N,N'-di-tert-butylethylenediamine (5.3 μL, d = 0.8 g / mL, 0.025 mmol) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 24 hours. The generated co-crystallized solid was filtered through a Bush funnel and washed with cold acetonitrile (2 mL, 0°C). The filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 20 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated, and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a light green solid (R)-1k (128.5 mg, 80% yield, 97% ee). 1 H NMR(400MHz,Chloroform-d)δ7.91(d,J=8.9Hz,1H),7.86-7.80(m,3H),7.37-7.26( m,4H),7.20(dd,J=9.0,1.9Hz,1H),7.06(t,J=8.3Hz,2H),5.15(s,1H),5.09(s,1H). 13C NMR (101 MHz, Chloroform-d) δ 152.8, 152.6, 133.3, 131.8, 131.5, 130.3, 130.0, 129.8, 129.4, 128.4, 128.1, 127.6, 127.0, 126.0, 124.1, 124.0, 119.0, 117.8, 111.4, 110.4. HPLC conditions: CHIRALPAKAD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 80:20, flow rate = 1.0 mL / min, t R =10.7min is the main enantiomer, t S =16.9min is the minor enantiomer. Fig.11 .

[0083] Example 12

[0084]

[0085] Under air conditions, rac-1l (182.6 g, 0.5 mmol) and acetonitrile (0.6 mL) were added to a 10 mL reaction tube containing a magnet. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (0.6 mL) was added dropwise under stirring. Then, CuCl (2.5 mg, 0.025 mmol) and N,N'-di-tert-butylethylenediamine (5.3 μL, d = 0.8 g / mL, 0.025 mmol) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 24 hours. The generated co-crystallized solid was filtered through a Bush funnel and washed with cold acetonitrile (2 mL, 0°C). The filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 20 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a green solid (R)-1l (163.7 mg, 90% yield, 97% ee). 1 H NMR(400MHz,Chloroform-d)δ8.04(s,1H),7.97(d,J=8.9Hz,1H),7.87(t,J=8.7Hz,2H),7 .40-7.34(m,5H),7.09(d,J=8.3Hz,1H),7.01(d,J=9.0Hz,1H),5.07(s,1H),4.98(s,1H). 13C NMR (101 MHz, Chloroform-d) δ 153.0, 152.7, 133.3, 132.0, 131.6, 130.6, 130.5, 130.4, 130.3, 129.4, 128.5, 127.6, 126.1, 124.1, 124.0, 118.9, 117.8, 111.4, 110.3. HPLC conditions: CHIRALPAK AD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 80:20, flow rate = 1.0 mL / min, t R =11.9min is the main enantiomer, t S =20.9min is the minor enantiomer. Fig.12 .

[0086] Embodiment 13

[0087]

[0088] Under air conditions, rac-1m (172.2 mg, 0.5 mmol) and acetone (0.5 mL) were added to a 10 mL reaction tube containing a magnet. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (0.6 mL) was added dropwise under stirring. Then, CuCl (2.5 mg, 0.025 mmol) and N,N'-di-tert-butylethylenediamine (5.3 μL, d = 0.8 g / mL, 0.025 mmol) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 48 hours. The generated co-crystallized solid was filtered through a Bush funnel and washed with cold acetone (2 mL, 0°C). The filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 5 mL) + H2O (15 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated, and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a light yellow solid (R)-1m (127.3 mg, 74% yield, 99% ee). 1 H NMR(400MHz,Chloroform-d)δ8.46(s,1H),7.93(d,J=8.9Hz,1H),7.88(d,J=8.9Hz,1H),7.70(d,J=8.6Hz,1H),7.36- 7.30(m,3H),7.27-7.23(m,1H),7.10(d,J=8.8Hz,1H),7.05(d,J=8.2Hz,1H),5.64(s,1H),5.55(s,1H),3.83(s,3H). 13C NMR (101 MHz, Chloroform-d) δ 167.2, 154.7, 152.9, 136.1, 133.4, 132.5, 131.4, 131.4, 129.3, 128.4, 128.2, 127.4, 126.7, 125.1, 124.5, 124.0, 118.6, 118.0, 111.9, 110.4, 52.2. HPLC conditions: CHIRALPAK OD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 80:20, flow rate = 1.0 mL / min, t S =10.7min for the minor enantiomer R =14.5min is the main enantiomer. Fig.13 .

[0089] Embodiment 14

[0090]

[0091] Under air conditions, rac-1n (31.4 mg, 0.1 mmol) and acetone (0.1 mL) were added to a 10 mL reaction tube containing a magnet. 2a, i.e., N-benzyl cinchonidine chloride (50.5 mg, 0.12 mmol) dissolved in dichloromethane (0.1 mL) was added dropwise under stirring. Then, CuCl (0.5 mg, 0.005 mmol) and N,N'-di-tert-butylethylenediamine (1.1 μL, d = 0.8 g / mL, 0.005 mmol) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 48 hours. The generated co-crystallized solid was filtered through a Bush funnel, washed with cold acetone (2 mL, 0°C), and the filtered solid was stirred with a mixture of hydrochloric acid (aq., 1M, 10 mL) and ethyl acetate (10 mL) until completely dissolved. The organic phase was separated, and the aqueous phase was extracted twice with ethyl acetate (20 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a white solid (R)-1n (23.2 mg, 74% yield, 99% ee). 1H NMR (400MHz, Chloroform-d) δ10.10(s,1H),8.39(s,1H),8.14(d,J=8.9Hz,1H),8.01(d,J=9.0Hz,1H),7.92(d,J=8.0Hz,1H),7.76(d,J=8.7 Hz,1H),7.49(d,J=8.9Hz,1H),7.42-7.38(m,2H),7.32(t,J=7.4Hz,1H),7.26-7.22(m,1H),7.09(d,J=8.4Hz,1H),5.35(s,1H),5.04(s,1H). 13 C NMR(101MHz,Chloroform-d)δ191.8,155.5,152.8,137.1,134.5,133.2,133.0,132.5,131.9 ,129.5,128.6,127.8,125.4,124.8,124.3,123.8,119.0,117.9,112.0,109.9.HRMS(EI)m / z calcd for C 21 H 14 O3[M] + :314.0937, found:314.0937.HPLC conditions: CHIRALPAK AD-H chiral column, 25°C, wavelength = 250 nm, n-Hexane / i-PrOH = 80:20, flow rate = 1.0 mL / min, t R =21.2min is the main enantiomer, t S =32.5min is the minor enantiomer. Fig.14 .

[0092] Embodiment 15

[0093]

[0094] Under air conditions, rac-1o (158.1 mg, 0.5 mmol) and acetonitrile (0.5 mL) were added to a 10 mL reaction tube containing a magnetic electron. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (0.5 mL) was added dropwise under stirring. Then, CuCl (2.5 mg, 0.025 mmol) and N,N'-di-tert-butylethylenediamine (5.3 μL, d = 0.8 g / mL, 0.025 mmol) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 24 hours. The generated co-crystallized solid was filtered through a Bush funnel, washed with cold acetonitrile (2 mL, 0°C), and the filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 20 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated, and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a yellow-green solid (R)-1o (109.7 mg, 69% yield, 97% ee). 1 H NMR(400MHz,Chloroform-d)δ7.91(d,J=8.8Hz,1H),7.85(d,J=7.9Hz,1H),7.81(d,J=8.9Hz,1H),7.36-7.26(m,4H), 7.18(s,1H),7.13(d,J=8.2Hz,1H),7.03(d,J=9.1Hz,1H),6.96-6.94(m,1H),5.14(s,1H),4.96(s,1H),3.87(s,3H). 13 C NMR (101 MHz, Chloroform-d) δ 156.3, 152.6, 151.0, 133.4, 131.2, 130.4, 129.9, 129.4, 128.6, 128.3, 127.4, 125.8, 124.2, 124.0, 119.8, 118.2, 117.7, 111.2, 111.1, 106.9, 55.3. HPLC conditions: CHIRALPAK OD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 90:10, flow rate = 1.0 mL / min, t S =18.3min for the minor enantiomer, t R =28.1min is the main enantiomer. Fig.15 .

[0095] Example 16

[0096]

[0097] Under air conditions, rac-1p (182.6 mg, 0.5 mmol) and acetone (0.5 mL) were added to a 10 mL reaction tube containing a magnet. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (0.6 mL) was added dropwise under stirring. Then, CuCl (2.5 mg, 0.025 mmol) and N,N'-di-tert-butylethylenediamine (5.3 μL, 0.025 mmol) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 48 hours. The generated co-crystallized solid was filtered through a Bush funnel, washed with cold acetone (2 mL, 0°C), and the filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 30 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated, and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a yellow-brown solid (R)-1p (122.5 mg, 67% yield, 67% ee). 1 H NMR(400MHz,Chloroform-d)δ8.24(s,1H),7.92(d,J=8.9Hz,1H),7.86(d,J=8.0Hz,1H),7.79 (d,J=8.1Hz,1H),7.39-7.25(m,5H),7.10(dd,J=15.2,8.4Hz,2H),5.59(s,1H),4.94(s,1H). 13 C NMR (101 MHz, Chloroform-d) δ 152.1, 148.9, 133.3, 133.1, 132.9, 131.3, 129.9, 129.3, 128.4, 127.8, 127.4, 127.4, 125.0, 124.6, 124.1, 124.0, 117.7, 113.2, 112.1, 111.8. HPLC conditions: CHIRALPAK OD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 90:10, flow rate = 1.0 mL / min, t R =14.8min is the main enantiomer, t S =25.5min is the minor enantiomer. Fig.16 .

[0098] Embodiment 17

[0099]

[0100] Under air conditions, rac-1q (189.6 mg, 0.5 mmol) and acetonitrile (0.5 mL) were added to a 10 mL reaction tube containing a magnetic electron. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (0.5 mL) was added dropwise under stirring. Then, [Cu(OH)Cl·TMEDA]2 (5.8 mg, 0.0125 mmol) was added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 24 h. The generated co-crystallized solid was filtered through a Bush funnel, washed with cold acetonitrile (2 mL, 0°C), and the filtered solid was stirred with a mixture of hydrochloric acid (aq., 1M, 20 mL) and ethyl acetate (20 mL) until completely dissolved. The organic phase was separated, and the aqueous phase was extracted twice with ethyl acetate (40 mL). All organic phases were collected, dried over anhydrous sodium sulfate, and separated and purified by column chromatography (petroleum ether: dichloromethane = 1 / 3) to obtain a light yellow solid (R)-1q (119.0 mg, 63% yield, 90% ee). 1 H NMR(400MHz,Chloroform-d)δ8.02(s,1H),7.87-7.83(m,2H),7.65(s,1H),7.38-7.29(m, 3H),7.14(d,J=8.4Hz,1H),6.99(t,J=9.0Hz,2H),5.11(s,1H),4.92(s,1H),2.46(s,3H). 13 C NMR(101MHz,Chloroform-d)δ152.9,152.0,133.8,132.0,131.4,130.9,130.6,130.5,130. 3,130.3,129.8,129.6,127.5,126.1,123.9,118.9,117.8,111.5,110.1,21.3.HRMS(EI)m / z calcd for C 21 H 15 81 BrO2[M] + :380.0232, found:380.0232.HPLC conditions: CHIRALPAK OD-H chiral column, 25°C, wavelength = 250 nm, n-Hexane / i-PrOH = 90:10, flow rate = 1.0 mL / min, t S =12.5min for the minor enantiomer, t R =25.9min is the main enantiomer. Fig.17 .

[0101] Embodiment 18

[0102]

[0103] Under air conditions, rac-1r (143.1 mg, 0.5 mmol), N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) and acetone (2.5 mL) were added to a 10 mL reaction tube containing a magnet. The reaction tube was sealed with a rubber septum and heated at 60 °C with stirring for 4 h. Subsequently, CuCl (2.5 mg, 0.025 mmol), N,N'-di-tert-butylethylenediamine (5.3 μL, 0.025 mmol) and acetone (0.5 mL) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and heated at 60 °C with stirring for 44 h. The generated co-crystallized solid was filtered through a Bush funnel and washed with cold acetonitrile (2 mL, 0°C). Ethyl acetate (40 mL), hydrochloric acid (aq., 0.02 M, 10 mL) and H2O (20 mL) were added to the bottle containing the filtered solid in sequence and stirred until completely dissolved. The organic phase was separated and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a gray solid (R)-1r (101.5 mg, 71% yield, 98% ee). 1 H NMR(400MHz,Chloroform-d)δ7.85(t,J=7.9Hz,2H),7.77(d,J=7.9Hz,1H),7.72(d,J=8.6Hz,1H),7.35(d,J=8.9Hz,1H) ,7.32-7.26(m,2H),7.24-7.19(m,2H),7.14(d,J=8.7Hz,1H),7.09(d,J=8.4Hz,1H),7.05(d,J=8.3Hz,1H),4.09(s,3H). 13 C NMR (101 MHz, Chloroform-d) δ 151.8, 143.7, 134.1, 133.2, 130.6, 130.3, 129.5, 128.3, 128.3, 128.2, 127.3, 126.9, 124.5, 123.7, 123.6, 122.7, 118.1, 117.7, 114.2, 108.5. HPLC conditions: CHIRALPAKAD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 80:20, flow rate = 1.0 mL / min, t R =9.5min is the main enantiomer, t S =18.3min is the minor enantiomer. Fig.18 .

[0104] Embodiment 19

[0105]

[0106] In air, rac-1s (142.1 mg, 0.5 mmol) and dichloromethane (1.2 mL) were added to a 10 mL reaction tube with a magnetic electron. 2a, i.e., N-benzyl cinchonidine chloride (252.6 mg, 0.6 mmol) dissolved in dichloromethane (0.5 mL) was added dropwise under stirring. Then, CuCl (5.0 mg, 0.05 mmol) and N,N'-di-tert-butylethylenediamine (10.6 μL, d = 0.8 g / mL, 0.05 mmol) were added to the reaction tube in sequence. Finally, the reaction tube was sealed with a rubber septum and stirred at 50°C for 48 hours. The generated co-crystallized solid was filtered through a Bush funnel and washed with cold acetonitrile (2 mL, 0°C). To the bottle containing the filter solid, ethyl acetate (40 mL), hydrochloric acid (aq., 0.02 M, 6 mL) and H2O (20 mL) were added in sequence and stirred until completely dissolved. The organic phase was separated and the aqueous phase was extracted twice with ethyl acetate (40 mL). All the organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a white solid (R)-1s (86.6 mg, 61% yield, >99% ee). 1 H NMR (400MHz, Chloroform-d) δ7.81-7.79(m,4H),7.23-7.19(m,4H),7.13(d,J=8.6Hz,2H),7.08(d,J=7.6Hz,2H),3.59(s,4H). 13 C NMR (101 MHz, Chloroform-d) δ 142.7, 133.7, 129.5, 128.5, 128.1, 126.8, 123.9, 122.4, 118.3, 112.6. HPLC conditions: CHIRALPAK OD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 90:10, flow rate = 1.0 mL / min, t S =29.5min for the minor enantiomer, t R =35.6min is the main enantiomer. Fig.19 .

[0107] Comparative Example

[0108] Comparative Example 1 (Traditional kinetic resolution method)

[0109]

[0110] In air, rac-1n (31.4 mg, 0.1 mmol) and acetone (0.1 mL) were added to a 10 mL reaction tube with a magnetic field. 2a, i.e., N-benzyl cinchonidine chloride (50.5 mg, 0.12 mmol) dissolved in dichloromethane (0.1 mL) was added dropwise under stirring. Finally, the reaction tube was sealed with a rubber septum and stirred at room temperature for 48 hours. The resulting co-crystallized solid was filtered through a Bush funnel, washed with cold acetone (2 mL, 0°C), and the filtered solid was stirred with a mixture of hydrochloric acid (aq., 1 M, 10 mL) and ethyl acetate (10 mL) until completely dissolved. The organic phase was separated, and the aqueous phase was extracted twice with ethyl acetate (20 mL). All organic phases were collected, dried over anhydrous sodium sulfate, and spin-dried to obtain a white solid (R)-1n (5.5 mg, 18% yield, 94% ee). HPLC conditions: CHIRALPAK AD-H chiral column, 25°C, wavelength = 250 nm, n-Hexane / i-PrOH = 80:20, flow rate = 1.0 mL / min, t R =21.3min is the main enantiomer, t S =32.4min is the minor enantiomer. Fig. 20 .

[0111] Comparative Example 2 (method of the present invention)

[0112]

[0113] The specific operation method is the same as that of Example 14 of the present invention.

[0114] Application Example Product Derivatization

[0115] Application Example 1

[0116]

[0117] Under nitrogen, (R)-1e (88.8 mg, 0.2 mmol), Pd(PPh3)4 (12.0 mg, 0.01 mmol), phenylboric acid (53.6 mg, 0.44 mmol), K2CO3 (82.9 mg, 0.6 mmol), tetrahydrofuran (1 mL) and H2O (1 mL) prepared in Example 5 of the present invention were added in sequence to a 15 mL dry sealed tube containing a magnetic electron. The reaction solution was stirred at 85°C for 18 hours and then cooled to room temperature. The reaction solution was extracted with dichloromethane (20 mL×3). All organic phases were collected, dried over anhydrous sodium sulfate, and separated and purified by column chromatography (petroleum ether:ethyl acetate=4 / 1) to obtain a light yellow solid (R)-1t (59.8 mg, 68% yield, 98% ee). 1HNMR(400MHz,Chloroform-d)δ8.11(s,2H),8.05(d,J=8.9Hz,2H),7.67(d,J=7.5Hz,4H),7.59(dd ,J=8.7,1.4Hz,2H),7.48-7.42(m,6H),7.37(d,J=7.3Hz,2H),7.26(d,J=3.3Hz,2H),5.11(s,2H). 13 C NMR (101 MHz, Chloroform-d) δ 152.8, 140.8, 137.0, 132.6, 131.8, 129.8, 128.9, 127.3, 127.2, 127.2, 126.4, 124.8, 118.2, 110.7. HPLC conditions: CHIRALPAK OD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 80:20, flow rate = 1.0 mL / min, t S =10.9min for the minor enantiomer, t R =22.7min is the main enantiomer. Fig.21 .

[0118] Application Example 2

[0119]

[0120] Under nitrogen, (R)-1e (88.8 mg, 0.2 mmol), Pd(PPh3)4 (12.0 mg, 0.01 mmol), CuI (1.5 mg, 0.008 mmol) and ultra-dry DMSO (1 mL) prepared in Example 5 of the present invention were added in sequence to a 15 mL dry sealed tube containing a magnetic electron. The reaction solution was stirred at 80°C for 5 hours and then cooled to room temperature. The reaction solution was washed with HCl (aq., 1 M, 10 mL), and the aqueous phase was extracted with ethyl acetate (20 mL×3). All organic phases were collected, washed with saturated NaCl, dried over anhydrous sodium sulfate, and separated and purified by column chromatography (petroleum ether: ethyl acetate = 5 / 1) to obtain a light yellow solid (R)-1u (83.0 mg, 85% yield, 99% ee). 1 HNMR(400MHz,Chloroform-d)δ8.10(s,2H),7.96(d,J=8.9Hz,2H),7.55(d,J=5.6Hz ,4H),7.41(t,J=7.4Hz,4H),7.35-7.34(m,6H),7.10(d,J=8.7Hz,2H),5.12(s,2H). 13C NMR (101 MHz, Chloroform-d) δ 153.4, 132.9, 131.9, 131.6, 131.4, 130.2, 129.1, 128.3, 128.3, 124.3, 123.3, 118.9, 118.5, 110.9, 89.7, 89.5. HPLC conditions: CHIRALPAKAD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 80:20, flow rate = 1.0 mL / min, t R =16.1min is the main enantiomer, t S =31.9min is the minor enantiomer. Fig. 22 .

[0121] Application Example 3

[0122]

[0123] Under nitrogen, (R)-1e (88.8 mg, 0.2 mmol), PdCl2(dppf)·CH2Cl2 (32.7 mg, 0.04 mmol) and n-pentylmagnesium bromide (1M in THF, 3 mL) prepared in Example 5 of the present invention were added in sequence to a 15 mL dry sealed tube containing a magnetic electron (at 0°C). The reaction solution was stirred at 85°C for 12 hours and then cooled to room temperature. The reaction solution was quenched with saturated NH4Cl solution and extracted with ethyl acetate (20 mL×3). All organic phases were collected and washed with saturated NH4Cl solution, saturated NaHCO3 solution and saturated NaCl solution in sequence, dried over anhydrous sodium sulfate, and separated and purified by column chromatography (petroleum ether:ethyl acetate=10 / 1) to obtain a colorless oily liquid (R)-1v (70.6 mg, 83% yield, 99% ee). 1 H NMR(400MHz,Chloroform-d)δ7.90(d,J=8.9Hz,2H),7.66(s,2H),7.35(d,J=8.9Hz,2H),7.16(dd,J=8.6,1.2Hz,2H),7 .08(d,J=8.6Hz,2H),4.97(s,2H),2.71(t,J=7.7Hz,4H),1.71-1.63(m,4H),1.36-1.34(m,8H),0.89(t,J=6.8Hz,6H). 13C NMR (101 MHz, Chloroform-d) δ 152.1, 138.6, 131.7, 130.8, 129.6, 129.0, 126.9, 124.1, 117.6, 110.9, 35.7, 31.6, 31.1, 22.6, 14.0. HPLC conditions: CHIRALPAK AD-H chiral column, 25 °C, wavelength = 250 nm, n-Hexane / i-PrOH = 90:10, flow rate = 1.0 mL / min, t R =8.2min is the main enantiomer, t S =20.6min is the minor enantiomer. Fig.23 .

[0124] Example of screening of racemization catalyst in formula B

[0125]

[0126] The present invention proposes that when X, Y of the chiral biaryl compound is OH or NH2, the racemization activity of the system using cuprous chloride as the copper salt and N,N'-di-tert-butylethylenediamine as the ligand is optimal. The specific results are shown in Tables 1 and 2.

[0127] Table 1 Screening of metal catalysts a

[0128]

[0129] a Reaction conditions: Racemization reaction was carried out using (R)-1a (>99% ee), metal catalyst (10 mol%), toluene (0.1 M) under air conditions at 40°C. b The ee value was measured by chiral high performance liquid chromatography.

[0130] Table 2 Screening ligands a

[0131]

[0132]

[0133] a Reaction conditions: Racemization reaction was carried out using (R)-1a (>99% ee), CuCl (10 mol%), ligand (10 mol%), toluene (0.1 M) under air conditions at 40°C. b The ee value was measured by chiral high performance liquid chromatography. c The solvent was DCM.

[0134] The present invention further proposes that when X=OH and Y=OMe of the chiral biaryl compound, other copper salts and ligands also have racemization activity for the biaryl compound, which is supplemented here. For chiral biaryl compounds with X=OH and Y=OMe, the racemization activity of the system with copper dibromide as the copper salt and no ligand is the best; the system with cuprous chloride as the copper salt and 4,7-diphenyl-1,10-phenanthroline or 4,4'-bis(trifluoromethyl)-2,2'-bipyridine or 2,9-di-n-butyl-1,10-o-phenanthroline as the ligand also has racemization activity, and the specific results are shown in Table 3.

[0135] Table 3 Racemization activity of other copper salts and ligands a

[0136]

[0137]

[0138] a Reaction conditions: Racemization was carried out using (S)-1b (99% ee), [Cu] (10 mol%), ligand (10 mol%), toluene (0.1 M) under air conditions at 40°C. b The ee value was measured by chiral high performance liquid chromatography.

[0139] Furthermore, the present invention explored the racemization activity of the optimal racemization system in Table 3 above, copper dibromide as copper salt, and the system without ligand in other solvents. The experimental results showed that the racemization system had the highest activity in toluene. The specific results are shown in Table 4. The subsequent dynamic deracemization process of chiral biaryl compounds with X=OH, Y=OMe is under study.

[0140] Table 4 Racemization activity of copper dibromide in other solvents a

[0141]

[0142] a Reaction conditions: Racemization reaction was carried out using (S)-1b (99% ee), CuBr2 (10 mol%), solvent (0.1 M) under air conditions at 40°C. b The ee value was measured by chiral high performance liquid chromatography.

[0143] The protection content of the present invention is not limited to the above embodiments. Without departing from the spirit and scope of the inventive concept, changes and advantages that can be thought of by those skilled in the art are included in the present invention and are protected by the attached claims.

Claims

1. A method for synthesizing a chiral biaryl compound, characterized in that: The synthesis method is to start from a racemic biaryl compound in a solvent, use a quaternary ammonium salt as a chiral reagent, a copper salt and a nitrogen-containing ligand to form a racemization catalytic system, or directly use a complex of copper and a nitrogen-containing ligand as a racemization catalyst, and efficiently construct an enantiomer-pure chiral biaryl compound at room temperature or under heating conditions; In the synthesis reaction, the racemic biaryl compound undergoes a dynamic deracemization process to generate an enantiomerically pure chiral biaryl compound, as shown in reaction formula (1): Among them, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 Each is independently selected from hydrogen, deuterium, alkyl, aryl, aromatic heterocyclic group, alkoxy, halogen, carboxylic acid group, carboxylate group, acyl group, amide group, nitro group, cyano group, sulfonyl group, sulfinyl group, trifluoromethyl group.

2. The method according to claim 1, characterized in that in, The aryl group is selected from phenyl, alkyl-substituted phenyl, alkoxy-substituted phenyl, and halogenated phenyl; the aromatic heterocyclic group is selected from five-membered heterocyclic ring, six-membered heterocyclic ring, and condensed heterocyclic ring.

3. The method according to claim 1, characterized in that In the method, a racemic biaryl compound, a quaternary ammonium salt and a solvent are added under air conditions at room temperature or under heating, a copper salt and a nitrogen-containing ligand or a complex of copper and a nitrogen-containing ligand is directly used as a racemization catalyst, the reaction time is 24-48 hours, the generated co-crystallized solid is filtered, the solvent is washed, the obtained filtered solid is stirred and dissolved with a mixed system of hydrochloric acid and ethyl acetate, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and spin-dried to obtain a chiral biaryl compound.

4. The method according to claim 1, characterized in that In the method, the molar ratio of the racemic biaryl compound: quaternary ammonium salt: copper salt: nitrogen-containing ligand is 1:1-1.2:0.05-0.1:0.05-0.1; and / or the heating temperature is room temperature to 60°C.

5. The method according to claim 1, characterized in that In the method, the quaternary ammonium salt is a chiral quaternary ammonium salt; and / or, the copper salt includes one or more of copper halide, cuprous halide, copper sulfate, copper oxide, cuprous oxide, copper fluoroborate, basic copper carbonate, cuprous acetate, copper acetate, thiophene-2-carboxylate copper (I), tetrakis (acetonitrile) tetrafluoroborate, cuprous trifluoromethanesulfonate, copper trifluoromethanesulfonate, and tetraacetonitrile copper hexafluorophosphate; and / or, the complex of copper and nitrogen-containing ligand includes one or more of dihydroxy-bis-tetramethylethylenediamine copper chloride, copper phthalocyanine (II), (1,10-phenanthroline) (trifluoromethyl) copper, and dichloro (1,10-phenanthroline) copper.

6. The method according to claim 1, characterized in that In the method, the nitrogen-containing ligand includes one or more of N,N'-di-tert-butylethylenediamine, N,N'-dimethylethylenediamine, N,N'-diethylethylenediamine, N,N'-diisopropylethylenediamine, N,N-diisopropylethylenediamine, tetramethylguanidine, metformin, 1,3-bis(dimethylamino)benzene, 2,2'-bipyridine, 6,6'-dimethyl-2,2'-bipyridine, 1,10-phenanthroline, 2,9-dimethyl-4,7-biphenyl-1,10-o-phenanthroline, 2,9-dimethyl-1,10-phenanthroline, 4,7-diphenyl-1,10-phenanthroline, 4,4'-bis(trifluoromethyl)-2,2'-bipyridine, and 2,9-di-n-butyl-1,10-o-phenanthroline.

7. The method according to claim 1, characterized in that In the method, the solvent includes one or more of acetonitrile, dichloromethane, cyclohexane, dimethyl sulfoxide, toluene, trifluorotoluene, acetone, tetrahydrofuran, ether, methyl tert-butyl ether, ethyl acetate, methanol, and ethanol.

8. The synthesis method according to claim 1, characterized in that In the reaction, the racemic biaryl compound is dissolved in a solvent, and the dissolved chiral quaternary ammonium salt is added dropwise while stirring, followed by the addition of copper salt and ligand in sequence, and the mixture is stirred for 24-48 hours at room temperature or under heating and air conditions.

9. The synthesis method according to claim 8, characterized in that After the reaction is completed, the reaction mixture is filtered using a Bush funnel and washed with a solvent. The obtained solid is stirred and dissolved with a mixed system of hydrochloric acid and ethyl acetate. The organic phase is separated using a separatory funnel, and the aqueous phase is extracted twice with ethyl acetate. The organic phases are combined, dried over anhydrous sodium sulfate, and spin-dried to obtain a chiral biaryl compound.

10. A chiral biaryl compound synthesized and prepared by the method according to any one of claims 1 to 9, characterized in that: The chiral biaryl compounds include β-binaphthol, derivatives of β-binaphthol, 2'-amino-2-hydroxy-1,1'-binaphthol, derivatives of 2'-amino-2-hydroxy-1,1'-binaphthol, 2,2'-diamino-1,1'-binaphthol and derivatives of 2,2'-diamino-1,1'-binaphthol.